{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:07:14Z","timestamp":1791493634456,"version":"4.3.4"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:00:00Z","timestamp":1717632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006756","name":"Brigham Young University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006756","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["P41-GM103311"],"award-info":[{"award-number":["P41-GM103311"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>ATTR amyloidosis is caused by deposition of large, insoluble aggregates (amyloid fibrils) of cross-\u03b2-sheet TTR protein molecules on the intercellular surfaces of tissues. The process of amyloid formation from monomeric TTR protein molecules to amyloid deposits has not been fully characterized and is therefore modeled in this paper. Two models are considered: 1) TTR monomers in the blood spontaneously fold into a \u03b2-sheet conformation, aggregate into short proto-fibrils that then circulate in the blood until they find a complementary tissue where the proto-fibrils accumulate to form the large, insoluble amyloid fibrils found in affected tissues. 2) TTR monomers in the native or \u03b2-sheet conformation circulate in the blood until they find a tissue binding site and deposit in the tissue or tissues forming amyloid deposits <jats:italic>in situ<\/jats:italic>. These models only differ on where the selection for \u03b2-sheet complementarity occurs, in the blood where wt-wt, wt-v, and v-v interactions determine selectivity, or on the tissue surface where tissue-wt and tissure-v interactions also determine selectivity. Statistical modeling in both cases thus involves selectivity in fibril aggregation and tissue binding. Because binding of protein molecules into fibrils and binding of fibrils to tissues occurs through multiple weak non-covalent bonds, strong complementarity between \u03b2-sheet molecules and between fibrils and tissues is required to explain the insolubility and tissue selectivity of ATTR amyloidosis. Observation of differing tissue selectivity and thence disease phenotypes from either pure wildtype TTR protein or a mix of wildtype and variant molecules in amyloid fibrils evidences the requirement for fibril-tissue complementarity. Understanding the process that forms fibrils and binds fibrils to tissues may lead to new possibilities for interrupting the process and preventing or curing ATTR amyloidosis.<\/jats:p>","DOI":"10.1371\/journal.pone.0304891","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:26:22Z","timestamp":1717694782000},"page":"e0304891","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modeling transthyretin (TTR) amyloid diseases, from monomer to amyloid fibrils"],"prefix":"10.1371","volume":"19","author":[{"given":"Richard S.","family":"Criddle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8581-9020","authenticated-orcid":true,"given":"Lee D.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Woodfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Dennis","family":"Tolley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,6,6]]},"reference":[{"issue":"21","key":"pone.0304891.ref001","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2015.09.075","article-title":"Diagnosis, prognosis, and therapy of transthyretin amyloidosis","volume":"66","author":"MA Gertz","year":"2015","journal-title":"JACC"},{"key":"pone.0304891.ref002","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.1038\/s41467-021-27481-4","article-title":"Structural basis for transthyretin amyloid formation in vitreous body of the eye","volume":"12","author":"I Iakovleva","year":"2021","journal-title":"Nat. Comm"},{"key":"pone.0304891.ref003","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nature03680","article-title":"Structure of the cross-\u03b2 spine of amyloid-like fibrils","volume":"435","author":"R Nelson","year":"2005","journal-title":"Nature"},{"key":"pone.0304891.ref004","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease","volume":"75","author":"F Chiti","year":"2006","journal-title":"Ann. Rev. Biochem"},{"key":"pone.0304891.ref005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.sbi.2019.09.001","article-title":"Amyloid structures: much more than just a cross-\u03b2 fold","volume":"60","author":"R Gallardo","year":"2020","journal-title":"Curr Opin Struct Biol"},{"issue":"6","key":"pone.0304891.ref006","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejhf.2198","article-title":"Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy","volume":"23","author":"P Garcia-Pavia","year":"2021","journal-title":"Eur. J. Heart Fail"},{"key":"pone.0304891.ref007","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nbt1012","article-title":"Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins","volume":"10","author":"A Fernandez-Escamilla","year":"2004","journal-title":"Nat. Biotech"},{"key":"pone.0304891.ref008","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.189928","article-title":"Amyloid assembly and disassembly","volume":"131","author":"E Chuang","year":"2018","journal-title":"J. Cell Sci"},{"key":"pone.0304891.ref009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Y Sekijima","year":"2005","journal-title":"Cell"},{"key":"pone.0304891.ref010","first-page":"127","volume-title":"Your inner fish: A journey into the 3.5-billion-year history of the human body","author":"N Shubin","year":"2009"},{"issue":"9","key":"pone.0304891.ref011","first-page":"E2403","volume":"35","author":"DM Rowczenio","year":"2014","journal-title":"Online registry for mutations in hereditary amyloidosis including nomenclature recommendations"},{"issue":"4","key":"pone.0304891.ref012","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: Update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"MD Benson","year":"2020","journal-title":"Amyloid J. Protein Folding Disorders"},{"issue":"1","key":"pone.0304891.ref013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jns.12153","article-title":"Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy","volume":"21","author":"I Concei\u00e7\u00e3o","year":"2016","journal-title":"J. Peripheral Nervous System"},{"issue":"3","key":"pone.0304891.ref014","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/13506129.2013.797890","article-title":"Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis","volume":"20","author":"E Ihse","year":"2013","journal-title":"Amyloid"},{"key":"pone.0304891.ref015","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1038\/s41467-019-13038-z","article-title":"Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis","volume":"10","author":"M Schmidt","year":"2019","journal-title":"Nat. Comm"},{"issue":"1","key":"pone.0304891.ref016","first-page":"2020","article-title":"Systemic aamyloidosis recognition, prognosis, and therapy. A systematic review","volume":"7324","author":"MA Gertz","journal-title":"JAMA"},{"issue":"48","key":"pone.0304891.ref017","doi-asserted-by":"crossref","first-page":"13851","DOI":"10.1073\/pnas.1610716113","article-title":"Amyloid fibrils from the N-terminal prion protein fragment are infectious","volume":"113","author":"J Choi","year":"2016","journal-title":"Proc. Natl. Acad. Sci"},{"key":"pone.0304891.ref018","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fmolb.2016.00017","article-title":"Historical and current concepts of fibrillogenesis and in vivo amyloidogenesis: Implications of amyloid tissue targeting","volume":"3","author":"R Kisilevsky","year":"2016","journal-title":"Front. Mol. Biosci"},{"issue":"32","key":"pone.0304891.ref019","first-page":"E6507","article-title":"Serum amyloid A forms stable oligomers that disrupt vesicles at lysosomal pH and contribute to the pathogenesis of reactive amyloidosis","volume":"114","author":"DL Gantz","year":"2017","journal-title":"Proc. Natl. Acad. Sci"},{"issue":"4","key":"pone.0304891.ref020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joim.12585","article-title":"One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition","volume":"281","author":"OB Suhr","year":"2017","journal-title":"J. Internal Med"},{"issue":"Suppl. 1","key":"pone.0304891.ref021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/13506129.2012.674074","article-title":"Senile systematic amyloidosis\u2019 regional differences, real or do they reflect different diagnostic suspicion and use of techniques?","volume":"19","author":"RH Falk","year":"2012","journal-title":"Amyloid"},{"key":"pone.0304891.ref022","first-page":"6398","article-title":"Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis Nat","volume":"13","author":"M Steinebrei","year":"2022","journal-title":"Comm"},{"issue":"2","key":"pone.0304891.ref023","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3109\/13506129.2016.1165197","article-title":"Biochemical characterization of vitreous amyloid formed after liver transplantation","volume":"23","author":"JJ Liepnieks","year":"2016","journal-title":"Amyloid"},{"key":"pone.0304891.ref024","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2009.07.028","article-title":"Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy","volume":"287","author":"H Koike","year":"2009","journal-title":"J. Neurol. Sci"},{"key":"pone.0304891.ref025","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/eurheartj\/ehs123","article-title":"Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective","volume":"34","author":"C Rapezzi","year":"2013","journal-title":"Eur. Heart J"},{"issue":"2","key":"pone.0304891.ref026","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.humpath.2010.06.014","article-title":"Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met","volume":"42","author":"A Tsuch-Suzuki","year":"2011","journal-title":"Human Pathology"},{"issue":"6880","key":"pone.0304891.ref027","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/416507a","article-title":"Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases","volume":"416","author":"M Bucciantini","year":"2002","journal-title":"Nature"},{"issue":"33","key":"pone.0304891.ref028","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.1021\/ja000459t","article-title":"The strength of hydrogen bonds in liquid water and around nonpolar solutes","volume":"122","author":"KAT Silverstein","year":"2000","journal-title":"J. Am. Chem. Soc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304891","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T17:26:46Z","timestamp":1717694806000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0304891"}},"subtitle":[],"editor":[{"given":"Divakar","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0304891","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,6]]}}}